Divestment ICIG Officially Acquires Evonik’s Lülsdorf Site in Germany

Source: Press release Evonik 1 min Reading Time

Related Vendors

Evonik has sold its Lülsdorf site along with its associated cyanuric chloride business in Wesseling, Germany to the International Chemical Investors Group. With this move, the Group has also acquired all the production units at the site.

Evonik's chemical site in Lülsdorf near Cologne, Germany now officially belongs to the International Chemical Investors Group. (Source:  Evonik)
Evonik's chemical site in Lülsdorf near Cologne, Germany now officially belongs to the International Chemical Investors Group.
(Source: Evonik)

Essen/Germany – The chemical site in Lülsdorf near Cologne, Germany now officially belongs to the International Chemical Investors Group (ICIG). The sale of the site, which was announced at the beginning of April, was completed on June 30 after the necessary approvals were obtained from the antitrust authorities, among others. Along with the Lülsdorf site, the associated cyanuric chloride business in Wesseling has also been transferred to ICIG.

The businesses were previously part of Evonik's Performance Materials Division. With their sale, Evonik has implemented the first step in divesting all three parts of the division. ICIG is taking over the more than 600 employees and all production facilities. Extensive protective rights have been agreed for employees.

Evonik had begun preparing for the sale in the fall of 2021. The preferred solution from the outset was to sell the site to a new owner. With ICIG, Evonik chose an experienced chemical investor with extensive expertise in site development. ICIG is already active with subsidiaries in the chlorine chemicals and specialty chemicals industries and plans to further expand the Lülsdorf site and the acquired businesses.

(ID:49603943)

Subscribe to the newsletter now

Don't Miss out on Our Best Content

By clicking on „Subscribe to Newsletter“ I agree to the processing and use of my data according to the consent form (please expand for details) and accept the Terms of Use. For more information, please see our Privacy Policy. The consent declaration relates, among other things, to the sending of editorial newsletters by email and to data matching for marketing purposes with selected advertising partners (e.g., LinkedIn, Google, Meta)

Unfold for details of your consent